Pharmacokinetics and bioavailability of metformin in horses

American Journal of Veterinary Research

Volumn 70, Issue 5, 2009, Pages 665-668

  Hustace, Jaime L ^a   Firshman, Anna M ^a   Mata, John E ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG STRUCTURE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORSE; INSULIN SENSITIVITY; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; STRUCTURE ANALYSIS; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; FEMALE; HORSES; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRAVENOUS; MALE; METFORMIN; TIME FACTORS;

ANIMALIA; EQUIDAE;

EID: 65749084412     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.70.5.665     Document Type: Article

References (23)

1. Bailey CJ, Turner RC. Metformin. N Engl J Med 1996;334:574-579.
2. DeFronzo RA. Pathogenesis of type 2 diabetes: implications for metformin. Drugs 1999;58:29-30.
3. Dunn CJ, Peters DH. Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. Drugs 1995;49:721-749.
4. Derosa G, D'Angelo A, Rogonesi PD, et al. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin. Intern Med J 2007;37:79-86.
5. Moon RJ, Bascornbe LA, Holt RI. The addition of metformin in type 1 diabetes improves insulin sensitivity, diabetic control, body composition, and patient well-being. Diabetes Obes Metab 2007;9:143-145.
6. Howlett HC, Bailey CJ. A risk-benefit assessment of metformin in type 2 diabetes mellitus. Drug Saf 1999;20:489-503.
7. Michels GM, Boudinot FD, Ferguson DC, et al. Pharmacokinetics of the antihyperglycemic agent metformin in cats. Am J Vet Res 1999;60:738-742.
8. Pentikäinen PJ, Neuvonen PJ, Penttilä A. Pharmacokinetics of metformin after intravenous and oral administration to man. Eur J Clin Pharmacol 1979;16:195-202.
9. Treiber KH, Kronfeld DS, Hess TM, et al. Evaluation of genetic and metabolic predispositions and nutritional nsk factors for pasture-associated laminitis in ponies. J Am Vet Med Assoc 2006;228:1538-1545.
10. Frank N, Elliot SB, Brandt LE, et al. Physical characteristics, blood hormone concentrations, and plasma lipid concentrations in obese horses with insulin resistance. J Am Vet Med Assoc 2006;228:1383-1390.
11. Kronfeld DS, Treiber KH, Hess TM, et al. Insulin resistance in the horse: definition, detection, and dietetics. J Anim Sci 2005;83(suppl E):E22-E31.
12. Johnson PJ. The equine metabolic syndrome peripheral Cushing's syndrome. Vet Clin North Am Equine Pract 2002;18:271-291.
13. Frank N. Diagnosis of equine metabolic syndrome, in Proceedings. Annu Meet Am Coll Vet Intern Med Forum 2007; 157-159.
14. Ralston SL. Insulin and glucose regulation. Vet Clin North Am Equine Pract 2002;18:295-304.
15. Sommardahl CS, Frank N, Elliott SB, et al. Effects of oral administration of levothyroxine sodium on serum concentrations of thyroid gland hormones and responses to injections of thyrotropin-releasing hormone in healthy adult mares. Am J Vet Res 2005;66:1025-1031.
16. Vick MM, Sessions DR, Murphy BA, et al. Obesity is associated with altered metabolic and reproductive activity in the mare: effects of metformin on insulin sensitivity and reproductive cyclicity. Reprod Fertil Dev 2006;18:609-617.
17. Johnson PJ, Scotty NC, Wiedmeyer C, et al. Diabetes mellitus in a domesticated Spanish Mustang. J Am Vet Med Assoc 2005;226:584-588.
18. Firshman AM, Valberg SJ. Factors affecting clinical assessment of insulin sensitivity in horses. Equine Vet J 2007;39:567-575.
19. Ross MS. Determination of metformin in biological fluids by derivatization followed by high performance liquid chromatography. J Chromatogr 1977;133:408-411.
20. Scheen AJ. Clinical pharmacokinetics of metformin. Clin Pharmacokinet 1996;30:359-371.
21. Sambol NC, Brookes LG, Chiang J, et al. Food intake and dosage level, but not tablet vs solution dosage form, affect the absorption of metformin HCl in man. Br J Clin Pharmacol 1996;42:510-512.
22. Stepensky D, Friedman M, Srour W, et al. Preclinical evaluation of pharmacokinetic-pharmcacodynamic rationale for oral CR metformin formulation. J Control Release 2001;71:107-115.
23. Stepensky D, Friedman M, Raz I, et al. Pharmacokinetic-pharmacodynamic analysis of the glucose-lowering effect of metformin in diabetic rats reveals first-pass pharmacodynamic effect.